- 首页
- Recombinant Human BTLA/CD272/B- and T-Lymphocyte Attenuator,BR
Recombinant Human BTLA/CD272/B- and T-Lymphocyte Attenuator,BR
Recombinant Human BTLA/CD272/B- and T-Lymphocyte Attenuator
(订货以英文名为准)猜你喜欢
CAS No:112758-40-4
CAS No:13292-87-0
CAS No:9004-74-4
CAS No:25322-68-3
CAS No:652-03-9
CAS No:38749-90-5
CAS No:34580-14-8
CAS No:95753-56-3
CAS No:115383-22-7
产品属性 Product Attributes
基本信息
别名: B- and T-Lymphocyte Attenuator;B- and T-Lymphocyte-Associated Protein;CD272;BTLA中文名称: Recombinant Human BTLA/CD272/B- and T-Lymphocyte Attenuator
规格: 10ug ; 50ug ; 500ug ; 1mg
外观(性状): Lyophilized from a 0.2 μm filtered solution of PBS, pH 7.4.
纯度: ≥95% as determined by reducing SDS-PAGE.
储存条件: Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months.
产品信息
背景说明: B- and T-Lymphocyte Attenuator (BTLA) is a single-pass type I membrane protein containing 1 Ig-like V-type (immunoglobulin-like) domain.BTLA expression is induced during activation of T cells,and BTLA remains expressed on Th1 cells but not Th2 cells.Like PD1 and CTLA4,BTLA interacts with a B7 homolog,B7H4.However,unlike PD-1 and CTLA-4,BTLA displays T-Cell inhibition via interaction with tumor necrosis family receptors (TNF-R),not just the B7 family of cell surface receptors.BTLA is a lymphocyte inhibitory receptor that inhibits lymphocytes during immune response.BTLA also is a ligand for tumor necrosis factor (receptor) superfamily,member 14 (TNFRSF14),also known as herpes virus entry mediator (HVEM).BTLA-HVEM complexes negatively regulate T-cell immune responses.来源: Human Cells
其它标识
内毒素: Less than 0.1 ng/ug(1 EU/ug)as determined by LAL test.产品介绍 Product Introduction
暂无数据注意事项 Considerations
1.本产品仅供科研使用。请勿用于医药、临床诊断或治疗,食品及化妆品等用途。请勿存放于普通住宅区。2.为了您的安全和健康,请穿好实验服并佩戴一次性手套和口罩操作。
3.实验结果可由多种因素影响,相关处理只限于产品本身,不涉及其他赔偿。